Preferred Label : Charcot-marie-tooth disease, axonal, type 2b2;
Symbol : CMT2B2;
CISMeF acronym : ARCMT2B; CMT2B2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Charcot-marie-tooth disease, axonal, autosomal recessive, type 2b2; Charcot-marie-tooth neuropathy, type 2b2; ARCMT2B; Charcot-marie-tooth disease, neuronal, type 2b2;
Description : Charcot-Marie-Tooth (CMT) disease constitutes a clinically and genetically heterogeneous
group of hereditary motor and sensory neuropathies. On the basis of electrophysiologic
criteria, CMT is divided into 2 major types: type 1, the demyelinating form, characterized
by a motor median nerve conduction velocity less than 38 m/s (see CMT1B; 118200);
and type 2, the axonal form, with a normal or slightly reduced nerve conduction velocity.
For a phenotypic description and a discussion of genetic heterogeneity of axonal CMT
type 2, see CMT2A1 (118210). Autosomal recessive forms of CMT are less frequent than
the autosomal dominant or X-linked forms. One form of autosomal recessive axonal CMT
(CMT2B1; 605588) is caused by mutation in the LMNA gene (150330) on chromosome 1q21.2-q21.3.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the polynucleotide kinase 3-prime phosphatase gene (PNKP, 605610.0007).;
Prefixed ID : #605589;
Origin ID : 605589;
UMLS CUI : C1854150;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)